FDA Inspection 738907 — King Bio Inc.

King Bio Inc. — FEI 1053442

The FDA completed an inspection of King Bio Inc. on August 10, 2011 in Asheville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 10, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Asheville, NC (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
185121 CFR 211.84(e)Rejecting When Specifications Not Met
188521 CFR 211.165(b)Microbiological testing
191221 CFR 211.166(a)Written program not followed
202621 CFR 211.192Quality control unit review of records
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications